CAVICIDE1. Technical Bulletin

Similar documents
METRIGUARD. Technical Bulletin

SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data

Clorox Germicidal Wipes & Spray. The Easy & Most Effective Way to Disinfect

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data

Medline Micro-Kill and Medline Micro-Kill+ Hard-Surface Germicidal Wipes Now With and Without Alcohol!

Cleaning and Disinfection Protocol Vegetative Bacteria

Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria

Cleaning & Sanitising Medical range. Working in harmony with nature to protect

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process

MICRO-ORGANISMS by COMPANY PROFILE

TECHNICAL BULLETIN PURELL Advanced with Aloe Instant Hand Sanitizer

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

< x 10 6 > % > 5.8

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Antimicrobial and toxicological profile of the new biocide Akacid plus Ò

New and Innovative Applications for Metals COPPER. Tony Lea International Copper Association

Antimicrobial Copper Touch Surfaces: A new tool for Infection Control and Prevention

Multi-Drug Resistant Organisms (MDRO)

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

What bugs are keeping YOU up at night?

Infection Linelist. Infections Occurred Between 10/1/ :00:00 AM To 11/1/ :00:00 AM 2RCW2. Gastroenteritis (Adult) Urinary Tract

What s next in the antibiotic pipeline?

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

Optimum-UV Clinical & Laboratory Evidence

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

AHFA 2016 Regulatory Summit. Antimicrobial Material Preservatives & Sustainability Considerations

3 Infection Prevention Solutions

Lamilux AntiBac. Maximum hygiene thanks to steril surfaces

A solution for current veterinary challenges

Liofilchem Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

PRODUCT SPECIFICATION EndoSan3

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

Health and Hygiene (Pty) Ltd. Reference Test Certificate Register for F10 Disinfectant Test description - testing body Test ref no.

Hospital Acquired Infections. Anucha Apisarnthanarak, MD Infectious Disease Division Thammasart University Hospital

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

CONTAGIOUS COMMENTS Department of Epidemiology

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Mike Apley Kansas State University

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus

Summary of the latest data on antibiotic resistance in the European Union

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

Presented by: Mary McGoldrick, MS, RN, CRNI

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Cipro for gram positive cocci in urine

SUMMARY OF TESTS BEING EXECUTED WITH OXILITE OR NEUTRAL OXILITE PRODUCED ON WPT WATER-MASTER EQUIPMENT.

Disinfectants and Antiseptics Reference tests register

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

WHY IS THIS IMPORTANT?

Two (II) Upon signature

Antimicrobial Stewardship Strategy: Antibiograms

EARS Net Report, Quarter

MASTITIS DNA SCREENING

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Problem: Hospital Acquired Infections

MRSA inactivation with Decon Formula (DF)

Appropriate antimicrobial therapy in HAP: What does this mean?

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

December 2012 Issue 1, Vol. 1. Healthcare-associated. Infections (HAI)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

EcoHydra Antimicrobial Handwash. Product Overview. Physical Properties. Product Description. Regulatory Compliance. Key Features and Benefits

Other Beta - lactam Antibiotics

The Need for Biocides in the Health-Care Sector

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

AMR epidemiological situation: ECDC update

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

HOSPITAL-ACQUIRED INFECTIONS AND QASM PATIENTS

ESCMID Online Lecture Library. by author

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Terry Talks Nutrition: Infectious microbes

RCH antibiotic susceptibility data

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

New Drugs for Bad Bugs- Statewide Antibiogram

Understanding the Hospital Antibiogram

SOFT Movement Survey of FMT Programs

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Microbiology ( Bacteriology) sheet # 7

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Pathogens commonly isolated from selected diseases

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Testimony of the Natural Resources Defense Council on Senate Bill 785

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

CONTAGIOUS COMMENTS Department of Epidemiology

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

Transcription:

CAVICIDE1 Technical Bulletin CaviCide1 is a multi-purpose disinfectant intended for use in cleaning, decontaminating and disinfecting hard non-porous, inanimate surfaces and non-critical instruments in hospitals, laboratories, and other critical care areas where environmental control of cross contamination between treated surfaces is important. CaviCide1 EPA Registration number: 46781-12 CaviCide1 has biocidal effectiveness against the following microorganisms with a 1 minute contact time: Mycobacterium tuberculosis var. bovis (BCG)(TB) Staphylococcus aureus Pseudomonas aeruginosa Salmonella enterica Acinetobacter baumannii Multi-Drug Resistant Acinetobacter baumannii Methicillin Resistant Staphylococcus aureus (MRSA) Vancomycin Resistant Enterococcus faecalis (VRE) Vancomycin Intermediate Staphylococcus aureus (VISA) Methicillin Resistant Staphylococcus epidermidis (MRSE) Klebsiella pneumoniae Bordetella pertussis Extended spectrum ß-lactamase Escherichia coli (ESBL) Staphylococcus aureus with Reduced Susceptibility to Vancomycin Trichophyton mentagrophytes Candida albicans Hepatitis B Virus (HBV) Human Immunodeficiency Virus Type 1(HIV-1) Herpes Simplex Virus Type 1 Herpes Simplex Virus Type 2 Influenza A Virus (H3N2) Hepatitis C Virus (HCV) Rotavirus Norovirus Human Coronavirus (not associated with Severe Acute Respiratory Syndrome or SARS) Adenovirus Type 2* * Note: a 3-minute contact time is required as indicated on the product label. CAVICIDE1 Technical Bulletin (Revised 3/8/2012) Page 1 of 7

Tuberculocidal Efficacy Studies Mycobacterium tuberculosis var. bovis (BCG)(TB) AOAC Tuberculocidal Activity of a Germicidal Spray Microbiotest. August 31, 2010 Laboratory ID # 198-529 Conclusion: CaviCide1 passed the AOAC Tuberculocidal Activity of a Germicidal Spray test when Mycobacterium tuberculosis var. bovis (BCG)(TB), containing a 5% organic load, was AOAC Tuberculocidal Activity of a Germicidal Spray Confirmatory Microbiotest. August 31, 2010 Laboratory ID # 198-534 Conclusion: CaviCide1 passed the AOAC Tuberculocidal Activity of a Germicidal Spray Confirmatory test when Mycobacterium tuberculosis var. bovis (BCG)(TB), containing a 5% organic load, was Bactericidal Efficacy Studies Staphylococcus aureus Pseudomonas aeruginosa Salmonella enterica AOAC Germicidal Spray Test HealthCare Microbiotest. April 27, 2010 Laboratory ID # 198-524 Conclusion: CaviCide1 passed the AOAC Germicidal Spray Test Healthcare when Staphylococcus aureus, Pseudomonas aeruginosa and Salmonella enteric, each containing a 5% organic load, were Acinetobacter baumannii AOAC Germicidal Spray Test Supplemental Acinetobacter baumannii Microbiotest. August 24, 2010 Laboratory ID # 198-549 Acinetobacter baumannii containing a 5% organic load, was exposed to CaviCide1 for one minute at Multi-Drug Resistant (MDR) Acinetobacter baumannii AOAC Germicidal Spray Test Supplemental Multi-Drug Resistant Acinetobacter baumannii Microbiotest. November 30, 2010 Laboratory ID # 198-610 Multi- Drug Resistant (MDR) Acinetobacter baumannii containing a 5% organic load, was exposed to CaviCide1 for one minute at Methicillin Resistant Staphylococcus aureus (MRSA) AOAC Germicidal Spray Test Supplemental Methicillin-Resistant Staphylococcus aureus (MRSA) Microbiotest. August 24, 2010 Laboratory ID # 198-550 Methicillin-Resistant Staphylococcus aureus (MRSA) containing a 5% organic load, was CAVICIDE1 Technical Bulletin (Revised 3/8/2012) Page 2 of 7

Vancomycin Resistant Enterococcus faecalis (VRE) AOAC Germicidal Spray Test Supplemental Vancomycin Resistant Enterococcus faecalis (VRE) Microbiotest. August 24, 2010 Laboratory ID # 198-551 Vancomycin Resistant Enterococcus faecalis (VRE) containing a 5% organic load, was Vancomycin Intermediate Staphylococcus aureus (VISA) AOAC Germicidal Spray Test Supplemental Vancomycin Intermediate Staphylococcus aureus (VISA) Microbiotest. August 25, 2010 Laboratory ID # 198-552 Vancomycin Intermediate Staphylococcus aureus (VISA) containing a 5% organic load, was Methicillin Resistant Staphylococcus epidermidis (MRSE) AOAC Germicidal Spray Test Supplemental Methicillin Resistant Staphylococcus epidermidis (MRSE) Microbiotest. August 25, 2010 Laboratory ID # 198-553 Methicillin Resistant Staphylococcus epidermidis (MRSE) containing a 5% organic load, was Klebsiella pneumoniae AOAC Germicidal Spray Test Supplemental Klebsiella pneumoniae Microbiotest. August 25, 2010 Laboratory ID # 198-561 Klebsiella pneumoniae containing a 5% organic load, was exposed to CaviCide1 for one minute at Bordetella pertussis AOAC Germicidal Spray Test Supplemental Bordetella pertussis Microbiotest. September 13, 2010 Laboratory ID # 198-562 Bordetella pertussis containing a 5% organic load, was exposed to CaviCide1 for one minute at Extended spectrum ß-lactamase Escherichia coli (ESBL) AOAC Germicidal Spray Test Supplemental Extended spectrum ß-lactamase Escherichia coli (ESBL) Microbiotest. August 25, 2010 Laboratory ID # 198-564 Extended spectrum ß-lactamase Escherichia coli (ESBL) containing a 5% organic load, was CAVICIDE1 Technical Bulletin (Revised 3/8/2012) Page 3 of 7

Staphylococcus aureus with Reduced Susceptibility to Vancomycin AOAC Germicidal Spray Test Supplemental Vancomycin Intermediate Staphylococcus aureus (VISA) Microbiotest. August 25, 2010 Laboratory ID # 198-552 Staphylococcus aureus with Reduced Susceptibility to Vancomycin containing a 5% organic load, was Fungicidal/ Yeast Efficacy Studies Trichophyton mentagrophytes AOAC Germicidal Spray Test Fungicidal Trichophyton mentagrophytes Microbiotest. August 31, 2010 Laboratory ID # 198-554 Conclusion: CaviCide1 passed the AOAC Germicidal Spray Test Fungicidal when Trichophyton mentagrophytes containing a 5% organic load, was exposed to CaviCide1 for one minute at Candida albicans AOAC Germicidal Spray Test Supplemental Candida albicans Microbiotest. August 25, 2010 Laboratory ID # 198-563 Candida albicans containing a 5% organic load, was exposed to CaviCide1 for one minute at Virucidal Efficacy Studies Hepatitis B Virus (HBV) Initial Virucidal Efficacy Test Duck Hepatitis B Virus (Surrogate for Human Hepatitis B Virus) Microbiotest, October 13, 2010 Laboratory ID # 198-555 Conclusion: CaviCide1 passed the Initial Virucidal Efficacy Test when Duck Hepatitis B Virus (Surrogate for Human Hepatitis B Virus), containing at least 5% organic soil, was exposed to CaviCide1 for one minute at Confirmatory Virucidal Efficacy Test Duck Hepatitis B Virus (Surrogate for Human Hepatitis B Virus) Microbiotest, September 7, 2010 Laboratory ID # 198-556 Conclusion: CaviCide1 passed the Confirmatory Virucidal Efficacy Test when Duck Hepatitis B Virus (Surrogate for Human Hepatitis B Virus), containing at least 5% organic soil, was Human Immunodeficiency Virus Type 1 (HIV-1) Virucidal Efficacy Test Human Immunodeficiency Virus Type 1 Microbiotest, October 13, 2010 Laboratory ID # 198-557 Conclusion: CaviCide1 passed the Virucidal Efficacy Test when Human Immunodeficiency Virus Type 1, containing at least 5% organic soil, was exposed to CaviCide1 for one minute at CAVICIDE1 Technical Bulletin (Revised 3/8/2012) Page 4 of 7

Herpes Simplex Virus Type 1 Virucidal Efficacy Test Herpes Simplex Virus 1 Microbiotest, August 30, 2010 Laboratory ID # 198-558 Conclusion: CaviCide1 passed the Virucidal Efficacy Test when Herpes Simplex Virus Type 1, containing at least 5% organic soil, was exposed to CaviCide1 for one minute at Herpes Simplex Virus Type 2 Virucidal Efficacy Test Herpes Simplex Virus 2 Microbiotest, October 13, 2010 Laboratory ID # 198-559 Conclusion: CaviCide1 passed the Virucidal Efficacy Test when Herpes Simplex Virus Type 2, containing at least 5% organic soil, was exposed to CaviCide1 for one minute at Influenza A Virus (H3N2) Virucidal Efficacy Test Human Influenza A Virus (H3N2) Microbiotest, August 30, 2010 Laboratory ID # 198-560 Conclusion: CaviCide1 passed the Virucidal Efficacy Test when Human Influenza A Virus (H3N2), containing at least 5% organic soil, was exposed to CaviCide1 for one minute at Hepatitis C Virus (HCV) Initial Virucidal Efficacy Test Bovine Viral Diarrhea Virus (Surrogate for Human Hepatitis C Virus) Microbiotest, August 30, 2010 Laboratory ID # 198-566 Conclusion: CaviCide1 passed the Initial Virucidal Efficacy Test when Duck Hepatitis C Virus (Surrogate for Human Hepatitis C Virus), containing at least 5% organic soil, was Confirmatory Virucidal Efficacy Test Bovine Viral Diarrhea Virus (Surrogate for Human Hepatitis C Virus) Microbiotest, August 31, 2010 Laboratory ID # 198-567 Conclusion: CaviCide1 passed the Confirmatory Virucidal Efficacy Test when Bovine Viral Diarrhea Virus (Surrogate for Human Hepatitis C Virus), containing at least 5% organic soil, was Rotavirus Virucidal Efficacy Test Human Rotavirus Microbiotest, August 30, 2010 Laboratory ID # 198-568 Conclusion: CaviCide1 passed the Virucidal Efficacy Test when Human Rotavirus, containing at least 5% organic soil, was Norovirus Initial Virucidal Efficacy Test Feline Calicivirus (Surrogate for Human Norovirus) Microbiotest, September 7, 2010 Laboratory ID # 198-571 Conclusion: CaviCide1 passed the Initial Virucidal Efficacy Test when Feline Calicivirus (Surrogate for Human Norovirus), containing at least 5% organic soil, was exposed to CaviCide1 for one minute at CAVICIDE1 Technical Bulletin (Revised 3/8/2012) Page 5 of 7

Confirmatory Virucidal Efficacy Test Feline Calicivirus (Surrogate for Human Norovirus) Microbiotest, October 13, 2010 Laboratory ID # 198-572 Conclusion: CaviCide1 passed the Confirmatory Virucidal Efficacy Test when Feline Calicivirus (Surrogate for Human Norovirus), containing at least 5% organic soil, was Human Coronavirus Virucidal Efficacy Test Human Coronavirus (299E strain) Microbiotest, August 30, 2010 Laboratory ID # 198-575 Conclusion: CaviCide1 passed the Virucidal Efficacy Test when Human Coronavirus (299E strain), containing at least 5% organic soil, was exposed to CaviCide1 for one minute at Adenovirus Type 2 Virucidal Efficacy Test Adenovirus Type 2 Microbiotest, November 8, 2010 Laboratory ID # 198-583 Conclusion: CaviCide1 passed the Virucidal Efficacy Test when Adenovirus Type 2, containing at least 5% organic soil, was exposed to CaviCide1 for three minutes at Toxicity Studies Acute Eye Irritation Study Acute Dermal Irritation Study Acute Inhalation Study Acute Dermal Toxicity Study Acute Oral Toxicity Study Skin Sensitization Study Acute Eye Irritation Study Acute Eye Irritation Study in Rabbits Stillmeadow, Inc. October 28, 2010 Laboratory ID # 14313-10 Conclusion: Three albino rabbits were employed to evaluate the potential acute eye irritation effects of CaviCide1. Based on the average irritation scores, CaviCide1 is rated moderately irritating. All positive effects cleared on Day 10. Acute Dermal Irritation Study Acute dermal Irritation Study in Rabbits Stillmeadow, Inc. October 8, 2010 Laboratory ID # 14314-10 Conclusion: Three albino rabbits were employed to evaluate the primary dermal irritation effects of CaviCide1. Based on the irritation scores, CaviCide1 is rated slightly irritating. Acute Inhalation Study Acute Inhalation Study in Rats Stillmeadow, Inc. November 5, 2010 Laboratory ID # 14312-10 Conclusion: CaviCide1 was evaluated for its acute inhalation toxicity potential in albino rats. As indicated by the data, the acute inhalation LC 50 is greater than 2.16mg/L. CAVICIDE1 Technical Bulletin (Revised 3/8/2012) Page 6 of 7

Acute Dermal Toxicity Acute Dermal Toxicity Study in Rats Stillmeadow, Inc. November 3, 2010 Laboratory ID # 14311-10 Conclusion: CaviCide1 was evaluated for its dermal toxicity potential and relative skin irritancy when a single undiluted dose was applied to the intact skin of albino rats. The estimated LD 50, as indicated by the data, was determined to be greater than 5050 mg/kg. Acute Oral Toxicity Acute Oral Toxicity (UDP) in Rats Stillmeadow, Inc. November 16, 2010 Laboratory ID # 14310-10 Conclusion: CaviCide1 was evaluated for its acute oral toxicity potential in female albino rats. The study revealed no observable abnormalities. The acute oral LD 50 is estimated to be greater than 5000mg/kg. Skin Sensitization Study Skin Sensitization Study in Guinea Pigs Stillmeadow, Inc. November 16, 2010 Laboratory ID # 14315-10 Conclusion: CaviCide1 was evaluated for its potential to produce a sensitizing reaction in short-haired albino guinea pigs. CaviCide1 produced no irritation during the test. CaviCide1 did not elicit a sensitizing reaction in guinea pigs. CAVICIDE1 Technical Bulletin (Revised 3/8/2012) Page 7 of 7